Mayo Clinic, an existing partner of the biomedical data platform developer, has contributed to its $60m series B round.
US-based medical data software developer Nference received $60m in series B funding on Wednesday from investors including medical research and care provider Mayo Clinic.
Although they were not specifically referenced by Nference in the funding announcement, the round also featured venture capital firms NTT Venture Capital and Matrix Partners as well as investment manager Matrix Capital Management, according to Fierce Biotech.
Nference has built a software platform that uses neural networks to synthesise biomedical data from a range of sources…
